Skip to content
  • Investors
  • News & Events
  • Contact Us
Rigel Pharmaceuticals
  • Who We Are
  • Pipeline
  • Products
  • Join Our Team
  • Investors
  • News
  • Contact Us
Rigel Pharmaceuticals
  • Who We Are
  • Pipeline
  • Products
  • Join The Team
  • Investors
  • News
  • Contact Us
Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • FAQ
  • Stock Data
    • Stock Quote
    • Charting
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Press Releases
  • Events & Presentations
  • Email Alerts

Rigel to Present at Jefferies 2019 London Healthcare Conference

Nov 13, 2019 7:30am EST

Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition

Nov 07, 2019 7:30am EST

Rigel Announces Third Quarter 2019 Financial Results

Nov 05, 2019 4:01pm EST

Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results

Oct 29, 2019 7:30am EDT

Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call

Oct 23, 2019 7:30am EDT

Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe

Oct 18, 2019 7:30am EDT

Rigel to Host Investor and Analyst Call on October 23, 2019

Oct 16, 2019 7:30am EDT

Rigel Secures Credit Facility for Up to $60 Million

Oct 02, 2019 7:00am EDT

Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia

Sep 23, 2019 7:30am EDT

Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference

Aug 28, 2019 7:30am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...31
    Next
    • Email Alerts
    • Tear Sheet
    • RSS News Feed
    • Terms of Use
    • Privacy Policy

    © 2021 Rigel Pharmaceuticals, Inc. All rights reserved.
    TAVALISSE and the Rigel arc logo are trademarks of Rigel Pharmaceuticals, Inc.
    TAVA_ITP-19277

    • facebook
    • twitter
    • linkedin
    © 2021 Rigel Pharmaceuticals • Powered by GeneratePress